Assembly Biosciences, Inc. (ASMB) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ASMB Revenue Growth
ASMB Revenue Analysis (2014–2025)
As of May 8, 2026, Assembly Biosciences, Inc. (ASMB) generated trailing twelve-month (TTM) revenue of $62.9 million, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q1 2026) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, ASMB's 5-year compound annual growth rate (CAGR) stands at -1.8%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $79.1 million in 2020.
When compared to Healthcare sector peers including ARWR (+14.1% YoY), GILD (+3.5% YoY), and REGN (+5.9% YoY), ASMB has underperformed the peer group in terms of revenue growth. Compare ASMB vs ARWR →
ASMB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ASMBCurrent | $63M | -100.0% | -1.8% | -16.8% | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% | |
 GILD | $29.4B | +3.5% | +3.6% | 40.1% | |
 REGN | $14.3B | +5.9% | +11.0% | 24.9% |
ASMB Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $72.3M | +153.5% | $72.2M | 99.8% | $-12,118,000 | -16.8% |
| 2024 | $28.5M | +298.2% | $28.5M | 100.0% | $-45,420,000 | -159.3% |
| 2023 | $7.2M | - | $-41,737,000 | -582.7% | $-64,646,000 | -902.5% |
| 2022 | $0 | -100.0% | $-69,080,000 | - | $-94,114,000 | - |
| 2021 | $6.3M | -92.1% | $6.3M | 100.0% | $-132,688,000 | -2121.7% |
| 2020 | $79.1M | +395.6% | $-22,232,000 | -28.1% | $-64,775,999 | -81.9% |
| 2019 | $16.0M | +7.8% | $-69,361,000 | -434.5% | $-102,713,000 | -643.4% |
| 2018 | $14.8M | +64.1% | $-57,937,000 | -391.4% | $-92,735,000 | -626.4% |
| 2017 | $9.0M | - | $-35,206,250 | -390.4% | $-52,226,878 | -579.1% |
| 2016 | $0 | - | $-80,251 | - | $-45,278,461 | - |
See ASMB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASMB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASMB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASMB — Frequently Asked Questions
Quick answers to the most common questions about buying ASMB stock.
Is ASMB's revenue growth accelerating or slowing?
ASMB revenue declined -100.0% year-over-year, contrasting with the 5-year CAGR of -1.8%. TTM revenue fell to $63M. This reverses the prior growth trend.
What is ASMB's long-term revenue growth rate?
Assembly Biosciences, Inc.'s 5-year revenue CAGR of -1.8% reflects the variable expansion pattern. Current YoY growth of -100.0% is below this long-term average.
How is ASMB's revenue distributed by segment?
ASMB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.